CLINICAL_TRIALS
trial_result
· 2022-10-10
Clinical Trial Update: Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia [Phase 1, Phase 2]
Summary
A phase 1/2 clinical trial evaluating leukemic dendritic cell vaccination in patients with acute myeloid leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mendus | Conditions: Acute Myeloid Leukemia (AML), Leukemic Dendritic Cell Vaccination | Phase 1, Phase 2 | Status: COMPLETED